Fas and Fas-ligand expression in human pancreatic cancer

Annals of Surgery

Volumn 231, Issue 3, 2000, Pages 368-379

  Kornmann, Marko ^a   Ishiwata, Toshiyuki ^a   Kleeff, Jörg ^a   Beger, Hans G ^b   Korc, Murray ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Med Sci I C240 ^*

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; FAS LIGAND;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOASSAY; LIGAND BINDING; MALE; NORTHERN BLOTTING; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ADOLESCENT; ADULT; ANTIGENS, CD95; APOPTOSIS; BASE SEQUENCE; BLOTTING, NORTHERN; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; FAS LIGAND PROTEIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0034012799     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200003000-00010     Document Type: Article

References (50)

1. Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66:233-243.
2. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75:1169-1178.
3. Cifone MG, De Maria R, Roncaioli P, et al. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 1994; 180:1547-1552.
4. Nagata N, Golstein P. The Fas death factor. Science 1995; 267:1449-1456.
5. Depraetere V, Golstein P. Fas and other cell death signaling pathways. Sem Immunol 1997; 9:93-107.
6. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 1996; 184:1075-1082.
7. Shiraki X, Tsuji N, Shioda T, et al. Expression of Fas ligand in liver metastases of human colonie adenocarcinomas. Proc Natl Acad Sci USA 1997; 94:6420-6425.
8. Von Reyher U, Strater J, Kittstein W, et al. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res 1998; 58:526-534.
9. Gutierrez-Steil C, Wrone-Smith T, Sun X, et al. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). J Clin Invest 1998; 101:33-39.
10. Martinez-Lorenzo MJ, Gamen S, Etxeberria J, et al. Resistance to apoptosis correlates with a highly proliferative phenotype and loss of Fas and CPP32 (caspase-3) expression in human leukemia cells. Int J Cancer 1998; 75:473-481.
11. Ungefroren H, Voss M, Janssen M, et al. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res 1998; 58:1741-1749.
12. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998; 48:6-29.
13. Oertel JE, Heffess CS, Oertel YC. Pancreas. In: Sternberg SS, ed. Diagnostic Surgical Pathology. New York: Raven; 1989:1057-1093.
14. Almoguera C, Shibata D, Forrester K, et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988; 53:549-554.
15. Barton CM, Staddon SL, Hughes CM, et al. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. BrJ Cancer 1991; 64:1076-1082.
16. Hahn SA, Schutte M, Hoque ATMS, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271: 350-360.
17. Korc M. Role of growth factors in pancreatic cancer. Surg Oncol Clin North Am 1998; 7:25-41.
18. Kornmann M, Ishiwata T, Beger HG, Korc M. Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions. Oncogene 1997; 15:1417-1424.
19. Sato T, Shinji I, Kitada S, Reed JC. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 1995; 268:411-415.
20. Kiriakidou M, Driscoll DA, Lopez-Guisa JM, Strauss JF 3d. Cloning and expression of primate Daxx cDNAs and mapping of the human gene to chromosome 6p21.3 in the MHC region. DNA Cell Biol 1997; 16:1289-1298.
21. Rehemutulla A, Hamilton CA, Chinnaiyan AM, Dixit VM. Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J Biol Chem 1997; 272:25783-25786.
22. Fulda S, Sieverts H, Friesen C, et al. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 1997; 57:3823-3829.
23. Giordano C, Stassi G, De Maria R, et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's Thyroiditis. Science 1997; 275:960-963.
24. Törmänen U, Eerola A-K, Rainio P, et al. Enhanced apoptosis predicts shortened survival in non-small cell lung cancer. Cancer Res 1995; 55:5595-5602.
25. Wright AS, Thomas LN, Douglas RC, et al. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat. J Clin Invest 1996; 98:2558-2563.
26. Cheng J, Zhou T, Changdan L, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263:1759-1762.
27. Kornmann M, Arber N, Korc M. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. J Clin Invest 1998; 101:344-352.
28. Yang X, Khosravi-Far R, Chang HY, Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 1997; 89:1067-1076.
29. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68:251-306.
30. Walker NI, Harmon BV, Gobe GC, Kerr JFR. Patterns of cell death. Methods Achiev Exp Pathol 1988; 13:18-54.
31. Golstein P, Ojcius DM, Young JD. Cell death mechanisms and the immune system. Immunol Rev 1991; 121:29-65.
32. Nagata S. Apoptosis by death factor. Cell 1997; 88:355-365.
33. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267:1456-1462.
34. Wyllie AH. Apoptosis and carcinogenesis. Eur J Cell Biol 1997; 73:189-197.
35. Hellquist HB, Oleunicka B, Jadner M, et al. Fas receptor is expressed in human lung squamous cell carcinomas, whereas bcl-2 and apoptosis are not pronounced: a preliminary report. Br J Cancer 1997; 76:175-179.
36. Horie S, Kano M, Higashihara E, et al. Expression of Fas in renal cell carcinoma. Jap J Clin Oncol 1997; 27:384-388.
37. Tachibana O, Lampe J, Kleihues P, Ohgaki H. Preferential expression of Fas/APO1 (CD95) and apoptotic cell death in perinecrotic cells of glioblastoma multiforme. Acta Neuropathol 1996; 92:431-434.
38. Niehans GA, Brunner T, Frizelle SP, et al. Human lung carcinoma express Fas ligand. Cancer Res 1997; 57:1007-1012.
39. Walker PR, Saas P, Dietrich PY. Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back. J Immunol 1997; 158: 4521-4524.
40. Green DR, Ware CF. Fas-ligand: privilege and peril. Proc Natl Acad Sci USA 1997; 94:5986-5990.
41. Strand S, Hofmann WJ, Hug H, et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nat Med 1996; 2:1361-1366.
42. Yanagisawa J, Takahashi M, Kanki H, et al. The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis. J Biol Chem 1997; 272:8539-8545.
43. Landowski TH, Qu N, Buyuksal I, Painter JS, Dalton WS. Mutations in the Fas antigen in patients with multiple myeloma. Blood 1997;90: 4266-4270.
44. Sheridan JP, Marsters SA, Pitti RM, et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997; 277:818-821.
45. Marsters SA, Sheridan JP, Pitti RM, et al. A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr Biol 1997; 7:1003-1006.
46. Schulze-Osthoff K, Walczak H, Droge W, Krammer PH. Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol 1994; 127:15-20.
47. Frasch SC, Nick JA, Fadok VA, et al. p38 mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils. J Biol Chem 1998; 273:8389-8397.
48. Salmon RA, Foltz IN, Young PR, Schrader JW. The p38 mitogen-activated protein kinase is activated by ligation of the T or B lymphocyte antigen receptors, Fas or CD40, but suppression of kinase activity does not inhibit apoptosis induced by antigen receptors. J Immunol 1997; 159:5309-5317.
49. Brenner B, Koppenhoefer U, Weinstock C, et al. Fas-or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153. J Biol Chem 1997; 272:22173-22181.
50. Juo P, Kuo CJ, Reynolds SE, et al. Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases. Mol Cell Biol 1997; 17:24-35.